Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man

Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man

The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) and the associated coronavirus disease 2019 (COVID-19) continue to spread throughout the world, causing more than 120 million infections. Several variants of concern (VOCs) have emerged and spread with implications for vaccine effi...

Full description

Bibliographic Details
Main Authors: Marco Fabiani, Katia Margiotti, Antonella Viola, Alvaro Mesoraca, Claudio Giorlandino
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Pathogens
Subjects:
COVID-19
immunity
SARS-CoV-2
P.1 variant
vaccine
Brazilian variant
Online Access:https://www.mdpi.com/2076-0817/10/5/614
id doaj-470161959afa496ba810c7a335f8f088
record_format Article
spelling doaj-470161959afa496ba810c7a335f8f0882021-06-01T00:17:43ZengMDPI AGPathogens2076-08172021-05-011061461410.3390/pathogens10050614Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old ManMarco Fabiani0Katia Margiotti1Antonella Viola2Alvaro Mesoraca3Claudio Giorlandino4Human Genetics Lab, ALTAMEDICA, Viale Liegi 45, 00198 Rome, ItalyHuman Genetics Lab, ALTAMEDICA, Viale Liegi 45, 00198 Rome, ItalyHuman Genetics Lab, ALTAMEDICA, Viale Liegi 45, 00198 Rome, ItalyHuman Genetics Lab, ALTAMEDICA, Viale Liegi 45, 00198 Rome, ItalyHuman Genetics Lab, ALTAMEDICA, Viale Liegi 45, 00198 Rome, ItalyThe novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) and the associated coronavirus disease 2019 (COVID-19) continue to spread throughout the world, causing more than 120 million infections. Several variants of concern (VOCs) have emerged and spread with implications for vaccine efficacy, therapeutic antibody treatments, and possible reinfections. On 17 March 2021, several VOCs were detected, including lineage B.1.1.7, first identified in the UK, B.1.351 in South Africa, Lineage P.1 (B.1.1.28.1) in Brazil, and novel Sub-Lineage A (A.23.1), reported in Uganda, and B.1.525, reported in Nigeria. Here, we describe an 83-year-old man infected with the SARS-CoV-2 P.1 variant after two doses of the BNT162b2 mRNA COVID-19 vaccine.https://www.mdpi.com/2076-0817/10/5/614COVID-19immunitySARS-CoV-2P.1 variantvaccineBrazilian variant
collection DOAJ
language English
format Article
sources DOAJ
author Marco Fabiani
Katia Margiotti
Antonella Viola
Alvaro Mesoraca
Claudio Giorlandino
spellingShingle Marco Fabiani
Katia Margiotti
Antonella Viola
Alvaro Mesoraca
Claudio Giorlandino
Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man
Pathogens
COVID-19
immunity
SARS-CoV-2
P.1 variant
vaccine
Brazilian variant
author_facet Marco Fabiani
Katia Margiotti
Antonella Viola
Alvaro Mesoraca
Claudio Giorlandino
author_sort Marco Fabiani
title Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man
title_short Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man
title_full Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man
title_fullStr Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man
title_full_unstemmed Mild Symptomatic SARS-CoV-2 P.1 (B.1.1.28) Infection in a Fully Vaccinated 83-Year-Old Man
title_sort mild symptomatic sars-cov-2 p.1 (b.1.1.28) infection in a fully vaccinated 83-year-old man
publisher MDPI AG
series Pathogens
issn 2076-0817
publishDate 2021-05-01
description The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) and the associated coronavirus disease 2019 (COVID-19) continue to spread throughout the world, causing more than 120 million infections. Several variants of concern (VOCs) have emerged and spread with implications for vaccine efficacy, therapeutic antibody treatments, and possible reinfections. On 17 March 2021, several VOCs were detected, including lineage B.1.1.7, first identified in the UK, B.1.351 in South Africa, Lineage P.1 (B.1.1.28.1) in Brazil, and novel Sub-Lineage A (A.23.1), reported in Uganda, and B.1.525, reported in Nigeria. Here, we describe an 83-year-old man infected with the SARS-CoV-2 P.1 variant after two doses of the BNT162b2 mRNA COVID-19 vaccine.
topic COVID-19
immunity
SARS-CoV-2
P.1 variant
vaccine
Brazilian variant
url https://www.mdpi.com/2076-0817/10/5/614
work_keys_str_mv AT marcofabiani mildsymptomaticsarscov2p1b1128infectioninafullyvaccinated83yearoldman
AT katiamargiotti mildsymptomaticsarscov2p1b1128infectioninafullyvaccinated83yearoldman
AT antonellaviola mildsymptomaticsarscov2p1b1128infectioninafullyvaccinated83yearoldman
AT alvaromesoraca mildsymptomaticsarscov2p1b1128infectioninafullyvaccinated83yearoldman
AT claudiogiorlandino mildsymptomaticsarscov2p1b1128infectioninafullyvaccinated83yearoldman
_version_ 1721415213530480640

Similar Items